If concomitant use cannot be avoided, initiate repaglinide tablets at 0.5 mg before each meal and do not exceed a total daily dose of 4 mg [see Drug Interactions (7.1), Clinical Pharmacology (12.3)]
My conclusion on BPC-Lx is therefore more cautious than my earlier convenience-focused editorial review: BPC-Lx may be the easiest format to use, but convenience and bioavailability are separate questions
Semaglutide: The Direct Comparison# Semaglutide is the only GLP-1 drug available in both oral and injectable forms at weight-management doses, enabling direct comparison: The OASIS 1 trial showed that high-dose oral semaglutide (50 mg daily) achieves weight loss comparable to injectable semaglutide (2.4 mg weekly)
39(4): 51426 Mitchell SC, Zhang AQ, Smith RL
14 Change the subject: If direct boundary-setting feels too hard, subtly change the subject
doi:10.1517/13543776.12.11.1599